Kootstra, Neeltje A.

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., et al. (2020) · Science

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 1,140

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science

Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research

Cited by 408

Gene Therapy with Viral Vectors

Kootstra, N. A., & Verma, I. M. (2003) · Annual Review of Pharmacology and Toxicology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 267

Next-generation sequencing of microRNAs uncovers expression signatures in polarized macrophages

Cobos Jiménez, V., Bradley, E. J., Willemsen, A. M., van Kampen, A. H. C., Baas, F., & Kootstra, N. A. (2014) · Physiological Genomics

MicroRNA in disease regulationImmune cells in cancer

Cited by 103